Related Experiment Video
Updated: Jul 3, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
The emerging role of docosahexaenoic acid in neuroinflammation
Sarah K Orr1, Richard P Bazinet
1University of Toronto, Department of Nutritional Sciences, Faculty of Medicine, FitzGerald Building, 150 College Street, Room 306, Toronto, ON M5S 3E2, Canada.
Abstract:
Epidemiological studies have linked fish consumption to lower rates of neurological diseases. Fish contains high levels of omega-3 polyunsaturated fatty acids (n-3 PUFA), and several lines of evidence suggest that the n-3 PUFA docosahexaenoic acid (DHA; 22:6n-3) acts in the brain via anti-apoptotic and neurotrophic pathways. In addition, DHA may act through anti-neuroinflammatory pathways, as DHA possesses anti-inflammatory properties in the periphery. Evidence from animal models has indicated that DHA and its derivatives (resolvin D1 and protectin D1) attenuate colitis, peritonitis and ischemic stroke. n-3 PUFA deprivation in rats decreases brain levels of DHA and increases markers of the brain arachidonic acid (20:4n-6) cascade, a proinflammatory pathway. Thus, chronic low intake of n-3 PUFA may predispose the brain to weak anti-inflammatory, as well as strong proinflammatory signals. Neurological disorders, including Alzheimer's disease, Parkinson's disease and major depression, display a neuroinflammatory component. n-3 PUFA supplementation, as well as drugs targeting brain PUFA metabolism, are promising candidates in the prevention and treatment of neurological disorders.
Related Concept Videos
Inflammation: Introduction
Gut-Brain Axis
Chronic Inflammation: Introduction
Inflammation
Neurogenesis and Regeneration of Nervous Tissue
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
